Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Nathalie Caplet
Wheat futures were mixed on Monday as traders adjusted their positions ahead of USDA's February WASDE report.
France is the largest animal health market in Europe and is home to several leading veterinary medicine producers. But big players such as Ceva Santé Animale, Virbac and Vétoquinol aside, what are the characteristics of the sector? Animal Pharm's French correspondent Nathalie Caplet looks at the efforts to stoke innovation in the region.
Over the past few years, the French animal health industry association (SIMV) has broadened its outlook and range of activities. It now represents the veterinary industry on all the major national committees relating to the health sector enabling it to communicate better what the animal health industry can bring to veterinarians and the wider society. Animal Pharm's France correspondent Nathalie Caplet reviews the SIMV's recent activity and focus.
Discreet, successful and unique, MedinCell which provides its long-acting delivery technology to both the human and animal health markets, is celebrating its ten-year anniversary and fourth year of commercial activities. Dr Alexandre Melin, business development director for animal health, provided Animal Pharm a glimpse inside a French company that combines novel drug delivery partnerships with strong social values
One year after its launch, Vetbreedge, an online initiative to bring content and services to French veterinarians, has reached a critical stage of development. Interviewed by Animal Pharm’s French correspondent Nathalie Caplet, Vetbreedge’s team explains that its ambition is for the platform to become an essential daily tool in most French clinics, in turn bringing opportunities for animal health companies.
The animal health industry in France, as in other countries, is small compared to its human health counterpart. However, a review of the activities of its national industry trade association, the SIMV, with its president Jean-Louis Hunault, shows that it is reactive, pro-active and almost hyper-active, writes Animal Pharm’s French correspondent Nathalie Caplet. The association is involved in initiatives to promote innovation and develop the market for animal health products and services